IR-Med Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRME research report →
About the company
IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility.
- CEO
- Oded Bashan
- IPO
- 2021
- Employees
- 3
- HQ
- Rosh Pinna, IL
Price Chart
- Market Cap
- $540.67K
- P/E
- -0.29
- P/S
- 20.80
- P/B
- -0.83
- EV/EBITDA
- -0.91
- Div Yield
- 0.00%
- Gross Margin
- 23.08%
- Op Margin
- -3319.23%
- Net Margin
- -6738.46%
- ROE
- 372.24%
- ROIC
- 230.13%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,899,000 · 61.32%
- EPS
- $-0.03 · 61.95%
- Op Income
- $-1,941,000
- FCF YoY
- 57.14%
- 52W High
- $0.06
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.62
- Avg Volume
- 3
Get TickerSpark's AI analysis on IRME
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IRME coverage
Recent articles, reports, and earnings notes.
No research on IRME yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IRME report →Similar companies
Peers in the same neighborhood.